![Thomas Uhlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Uhlin
No más puestos en curso
Health Technology
Perfil
Thomas Uhlin was the Chief Executive Officer of Aprea Therapeutics AB and held Principal positions at Orexo AB and Doxa AB.
Antiguos cargos conocidos de Thomas Uhlin.
| Empresas | Cargo | Fin |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| DOXA AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Doxa AB
 Doxa AB Medical SpecialtiesHealth Technology Develops, manufactures, and commercializes bio ceramic dental products | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Uhlin
